Kudo, S <br/><br/>
Involvement of human cytochrome P450 3A4 in reduced haloperidol oxidation.  [electronic resource] 

 -  European journal of clinical pharmacology  May 1998 
 - 253-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0031-6970 
<br/><br/><label>Standard No.: </label>10.1007/s002280050455  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Arrhythmia Agents--pharmacology<br/>Anti-Bacterial Agents--administration & dosage<br/>Antiparkinson Agents--pharmacology<br/>Biotransformation--drug effects<br/>Biperiden--pharmacology<br/>Carteolol--metabolism<br/>Cell Line, Transformed<br/>Cytochrome P-450 CYP2D6--metabolism<br/>Cytochrome P-450 CYP2D6 Inhibitors<br/>Cytochrome P-450 CYP3A<br/>Cytochrome P-450 Enzyme Inhibitors<br/>Cytochrome P-450 Enzyme System--metabolism<br/>Dose-Response Relationship, Drug<br/>Haloperidol--antagonists & inhibitors<br/>Humans<br/>Hydroxylation--drug effects<br/>Isoenzymes--antagonists & inhibitors<br/>Kinetics<br/>Microsomes--drug effects<br/>Mixed Function Oxygenases--antagonists & inhibitors<br/>Oxidation-Reduction--drug effects<br/>Quinidine--pharmacology<br/>Sparteine--pharmacology<br/>Troleandomycin--administration & dosage